Екатерина Владимировна Чернова

Екатерина Владимировна Чернова

Auto-generated profile, based on publicly available information

Екатерина Владимировна Чернова

North-Western State Medical University Named After I.I. Mechnikov

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2018 in HERALD of North-Western State Medical University named after I.I. Mechnikov
Verified
Journal Article
Open access
PDF file
YCYekaterina V. Chernova
Yekaterina V. Chernova
ЧВЧернова Екатерина Владимировна
Чернова Екатерина Владимировна
Von Willebrand factor is a multimeric glycoprotein which appears to be one of the most important clotting factors providing an implementation of bleeding stop mechanism. This hemostatic protein represents a poly-functional molecule which performs its physiologic functions by taking an active part in initiation of platelets adhesion in the area of vessel endothelium damage. Moreover, von Willebrand factor bonds with collagen which is exposed when a vessel wall is damaged. Another important feature of von Willebrand factor is co-factor activity related to clotting factor VIII, manifesting in stabilization of the latter, providing its physiological clearance and its delivery to the vessel endothelium damage site. Genetically determined quantitative or qualitative von Willebrand factor deficiency leads to development of the most frequent hemostasis system disease — von Willebrand disease. The unique feature of von Willebrand factor is a waveform pattern of its functional activity. Von Willebrand factor may also appear as a ligand for large platelet integrin αIIbβ3 (GPIIb/IIIa). The role of von Willebrand factor in angiogenesis process is currently actively studied. It was shown that absence of von Willebrand factor promotes processes of angiogenesis which is manifested in significant increase of proliferation rate of endothelium cells in vitro.

22 October 2022 in Russian journal of hematology and transfusiology
Verified
Journal Article
Open access
PDF file
EBE. L. Beliaeva
E. L. Beliaeva
AKA. V. Koloskov
A. V. Koloskov
IGI. M. Gutkin
I. M. Gutkin
OPO. I. Philippova
O. I. Philippova
ECE. V. Chernova
E. V. Chernova
GDG. B. Dorofeeva
G. B. Dorofeeva
Introduction. The hemostasis system plays a key role in the pathogenesis of cardiovascular diseases.Aim — to evaluate changes in quantitative and qualitative characteristics of ADAMTS13 metalloprotease and von Willebrand factor an tigen (vWF:Ag) in patients with acute myocardial in farction (AMI) and is chemic stroke (IS).Patients and methods. The study in cluded 110 patients aged 42–95 years (median age — 64 years), of which: 65 patients with AMI aged 42–81 years (median age — 56 years) who had coronary artery thrombosis during an giography, as well as 45 patients with IS aged 40–95 years (median age — 70 years) with diagnosed cerebral artery thrombosis. All patients were tested for ADAMTS13 an tigen, ADAMTS13 activity, an tibodies to ADAMTS13 and vWF:Ag. Blood samples were obtained during an giography (arterial and venous blood) and 24 and 120 hours after an giography (venous blood).Results. In the group of patients with AMI, an in crease in the values of the vWF:Ag in dicator was revealed, which went beyond the upper limit of the reference in terval. In patients with IS, at the beginning of the study, this in dicator was within the reference in terval and was statistically significantly lower compared to patients with AMI but in creased after 24 hours and peaked at 120 hours. When an alyzing changes in the ADAMTS13:Ag in dicator, it was found that it was statistically significantly higher at all points of the study in the group of patients with AMI, compared with the group of patients with IS, however, the values of this in dicator did not go beyond the reference in terval in patients of both groups. At the same time, the ADAMTS13:AC in dex at all points of the study was statistically significantly higher in patients with IS, compared with the group of patients with AMI, and the ADAMTS13:AB in dex. On the contrary, in the group of AMI patients, this in dicator was statistically significantly higher in all points of the study when compared with that for the group of patients with IS.Conclusion. The study of two pathogenetic models of thrombosis demonstrated the absence of a relationship between the vWF:Ag in dex and the quantitative or qualitative characteristics of the ADAMTS13 metalloprotease. At the same time, an in crease in ADAMTS13:AB in AMI can be considered as the reason for the decrease in ADAMTS13:AC in these patients.

6 July 2022 in Russian journal of hematology and transfusiology
Verified
Journal Article
Open access
PDF file
AKA. V. Koloskov
A. V. Koloskov
AMA. A. Mangushlo
A. A. Mangushlo
EBE. L. Beliaeva
E. L. Beliaeva
OPO. I. Philippova
O. I. Philippova
ECE. V. Chernova
E. V. Chernova
VMV. N. Marchenko
V. N. Marchenko
Introduction. Currently, considerable attention is being given to the study of the interaction of the von Willebrand factor (vWF) and its specific regulator of metalloprotease ADAMTS13 in various clinical conditions accompanied by the development of thrombosis.Aim — to assess the change in the activity of ADAMTS13 metalloprotease and vWF factor antigen in patients with acute coronary syndrome during the first five days after the onset of an anginal attack.Patients and methods: The study included 90 patients aged 42 to 86 years (Me — 61.5 y.o.) hospitalized with a diagnosis of acute coronary syndrome. Of these, 69 were men (Me — 59 y.o.) and 21 women (Me — 63 y.o.). All patients were tested for ADAMTS13 activity, ADAMTS13 antigen, and vWF antigen. Blood samples for the study were obtained upon admission to the hospital (arterial and venous blood), as well as 24, 72 and 120 hours after hospitalization (venous blood).Results. It was found that at all points of the study, in patients without coronary artery thrombosis, the average value of the ADAMTS13 activity indicator was significantly higher compared to the group of patients with coronary artery thrombosis. At the same time, there were no statistically significant differences in the average values of the ADAMTS13 antigen between the compared groups of patients. The mean value of vWF antigen in patients with coronary artery thrombosis was significantly higher compared to that of patients without coronary artery thrombosis.Conclusion. An increase in ADAMTS13 activity was noted more often in patients with acute coronary syndrome without coronary artery thrombosis than in patients with coronary artery thrombosis, which may indicate the antithrombotic effect of ADAMTS13 metalloprotease. No differences were found in ADAMTS13 antigen levels when comparing the study groups of patients, which indicates a greater significance for the anticoagulant activity of the functional characteristics of ADAMTS13. Significantly higher levels of the vWF antigen in patients with coronary artery thrombosis were due to the response to ischemic myocardial injury and stress but were not the primary cause of the thrombotic event.

22 June 2024 in Тромбоз, гемостаз и реология
Verified
Journal Article
Closed access
ЕБЕлена Леонидовна Беляева
Елена Леонидовна Беляева
АКАндрей Викторович Колосков
Андрей Викторович Колосков
ЮДЮлианна Владиславовна Дивакова
Юлианна Владиславовна Дивакова
СКСофья Алексеевна Каралевич
Софья Алексеевна Каралевич
ИТИлана Петровна Токарева
Илана Петровна Токарева
ОФОльга Ильинична Филиппова
Ольга Ильинична Филиппова
Введение. Эндотелий сосудистого русла играет роль важнейшей регуляторной системы организма, реализуя свои функции посредством биологически активных молекул, таких как Р-селектин. Дисфункция эндотелия сопровождает значи­тельное количество патологических процессов в организме, в том числе атеросклероз и сепсис. Развитие тромботических осложнений атеросклероза на фоне дисфункции эндотелия и нарушения гемокоагуляции относится к наиболее часто реализуемым патологическим состояниям. Цель исследования: сравнить значения Р-селектина, как одного из маркеров дисфункции эндотелия, у пациентов с сепсисом различной этиологии без тромботических осложнений и у пациентов с тромбозами коронарных и церебральных артерий; изучить динамику значений Р-селектина в период первых 120 ч с момента установления диагноза острой сердечно-сосудистой патологии. Материалы и методы. В наблюдательное сравнительное неконтролируемое исследование включены 93 пациента в возрасте от 36 до 86 (медиана (Ме) = 69) лет: 48 мужчин в возрасте от 36 до 85 (Ме = 61) лет и 45 женщин от 42 до 85 (Ме = 73) лет. Пациенты были разделены на 3 группы в зависимости от характера основной патологии. В группу 1 вошли 45 пациентов, у которых течение основной соматической или хирургической патологии осложнилось сепсисом, но не сопровождалось развитием тромбозов; в группу 2 вошел 21 пациент с острым инфарктом миокарда (ОИМ), сопровождавшимся тромбозом в коронарном бассейне; группу 3 составили 27 больных с острым нарушением мозгового кровообращения (ОНМК) по ишемическому типу на фоне тромбоза крупной церебральной артерии. У всех включенных в исследование пациентов, находившихся на лечении в отделениях реанимации и интенсивной терапии стационара, иммуноферментным методом определяли содержание Р-селектина при поступлении в стационар (в артериальной и венозной крови), а также через 24 и 120 ч от момента госпитализации (в венозной крови). Результаты. Уровень Р-селектина у пациентов группы 1 (1213,0 [1027,0–1342,0] нг/мл) был статистически значимо выше (р < 0,001), чем у пациентов групп 2 (280,7 [245,2–761,0] нг/мл) и 3 (290,4 [248,6–425,1] нг/мл) в артериальной крови, полученной при поступ­лении в стационар. Заключение. Р-селектин, как маркер гемокоагуляционного и воспалительного звена эндотелиальной дисфункции, при сепсисе без тромботических осложнений демонстрирует более высокие значения в сравнении с острыми сердечно-сосудистыми заболеваниями, сопровождающимися тромбозами в коронарном и церебральных бассейнах, что свидетельствует о преимущественной ассоциации уровня Р-селектина с выраженностью воспалительного ответа и/или системной воспалительной реакции, которая при сепсисе существенно больше. Introduction. Vascular endothelium is the most important regulatory system in the body, functioning through biologically active molecules such as P-selectin. Endothelial dysfunction accompanies a significant number of pathological processes, including atherosclerosis and sepsis. One of the most common pathological conditions is the development of thrombotic complications of atherosclerosis in the context of endothelial dysfunction and impaired hemocoagulation. Aim: to compare P-selectin levels in endothelial dysfunction in patients with somatic pathology complicated by sepsis without thrombotic events and in patients with myocardial infarction and ischemic stroke due to thrombosis in the coronary and cerebral basins during the first 120 hours after diagnosis. Materials and Мethods. The observational, comparative, uncontrolled study included 93 patients aged 36 to 86 (median age (Ме) = 69) years: 48 men aged 36 to 85 (Ме = 61) years and 45 women aged 42 to 85 (Ме = 73) years. Patients were divided into 3 groups: group 1 included 45 patients with sepsis but without thrombotic events; group 2 included 21 patients with acute myocardial...

10 August 2019 in Russian journal of hematology and transfusiology
Verified
Journal Article
Open access
AKA. V. Koloskov
A. V. Koloskov
ECE. V. Chernova
E. V. Chernova
Background.Von Willebrand disease is a hereditary malfunction of the blood coagulation system caused by waveform quantitative and/or qualitative deficiency of von Willebrand factor (vWF).Aim.To evaluate the frequency of occurrence of FVLeiden and FII G20210A mutations in female patients with von Willebrand type 1 disease.Materials and methods.136 women aged from 18 to 45 years (mean 31.7 ± 0.5 years) were enrolled in a study conducted during the January 2011 — December 2017 period. Questionnaire was used to reveal hemorrhagic diathesis. Inclusion criteria were as follows: no less than 3 positive responses to questions 1–7, or 2 positive responses to questions 1–7 plus no less than 100 points of the evaluated menstrual blood loss. An independent inclusion criterion was 180 points or more in the question concerning menstrual blood loss. A mandatory inclusion criterion was the confirmation of absence of thromboembolic events in a proband and first line relatives. The study included assessment of such parameters as ristocetin-cofactor activity of von Willebrand factor (vWF:RCo), von Willebrand factor antigen (vWF:Ag), factor VIII (FVIII:C), platelet aggregation induced with ADP, ristomycin, collagen, as well as molecular-genetic assay of factor V (FVLeiden) and gene (FII G20210A) polymorphism using allele-specific polymerase chain reaction.Results.No mutations of FVLeiden and FII G20210A were revealed in 102 women with von Willebrand disease type 1. Heterozygous mutation of FVLeiden was found in 12 (8.8 %) subjects with von Willebrand disease type 1 (vWF:RCo from 27 to 47 % (mean 37.3 ± 0.8 %), vWF:Ag from 25 to 46 % (mean 37.5 ± 0.8 %), FVIII:C from 29 to 49 % (mean 44.1 ± 0.5 %). Homozygous mutation of FVLeiden was identified in 3 (2.2%) women with von Willebrand disease type 1, with vWF:RCo being 40, 43 and 45 %, vWF:Ag — 39, 44 and 42 %, FVIII:C — 47, 45 and 48 %, respectively. Heterozygous mutation FII G20210A was detected in 19 (13.9 %) subjects with von Willebrand disease type 1 (vWF:RCo from 36 to 49 % (mean 43.0 ± 0.4 %), vWF:Ag from 32 to 46 % (mean 42.2 ± 0.6 %), FVIII:C from 30 to 49 % (mean 45.1 ± 0.4 %).Conclusion.By means of diminishing the coagulation potential of the blood coagulation system, a decrease in the activity of VIII and von Willebrand factors may compensate possible negative effects associated with FVLeiden and FII G20210A gene mutations in female patients with von Willebrand type 1 disease.

12 May 2023 in Russian journal of hematology and transfusiology
Verified
Journal Article
Open access
PDF file
AKA. V. Koloskov
A. V. Koloskov
MVM. Yu. Vasileva
M. Yu. Vasileva
OPO. I. Philippova
O. I. Philippova
ECE. V. Chernova
E. V. Chernova
EBE. L. Beliaeva
E. L. Beliaeva
VMV. N. Marchenko
V. N. Marchenko
   Introduction. Along with the quantitative characteristics of the von Willebrand factor (vWF), more attention is paid to its qualitative characteristics in patients with von Willebrand disease (vWD).   Aim — to evaluate the frequency of vWF binding capacity disorders with type I collagen (vWF:CBAI) and type III collagen (vWF:CBAIII) in patients diagnosed with type 1 vWD and the diagnostic capabilities of these tests.   Material and methods. The prospective study included 224 female patients with previously diagnosed vWD type 1. The following tests were performed in the venous blood sample: von Willebrand factor antigen (vWF:Ag), vWF:CBAI, vWF:CBAIII. The control group consisted of 80 healthy female blood donors.   Results. In the control group, the values of vWF:CBAI and vWF:CBAIII did not exceed the reference intervals. A decrease in vWF:CBAI was detected in 133 (59.4 %) patients and vWF:CBAIII in 26 (11.6 %) patients. An isolated decrease in vWF:CBAI was detected in 87 (38.8 %) patients . An isolated decrease in vWF:CBAIII was less common — in 6 (2.7 %) patients.   Conclusion. The study of vWF:CBAI and vWF:CBAIII appears to be useful as an additional diagnostic test to improve the distinction between healthy individuals and those with VWD.